Pharmacoeconomics.

British Journal of Clinical Pharmacology
Dyfrig A Hughes

Abstract

Pharmacoeconomics is an essential component of health technology assessment and the appraisal of medicines for use by UK National Health Service (NHS) patients. As a comparatively young discipline, its methods continue to evolve. Priority research areas for development include methods for synthesizing indirect comparisons when head-to-head trials have not been performed, synthesizing qualitative evidence (for example, stakeholder views), addressing the limitations of the EQ-5D tool for assessing quality of life, including benefits not captured in quality-adjusted life years (QALYs), ways of assessing valuation methods (for determining utility scores), extrapolation of costs and benefits beyond those observed in trials, early estimation of cost-effectiveness (including mechanism-based economic evaluation), methods for incorporating the impact of non-adherence and the role of behavioural economics in influencing patients and prescribers.

References

May 1, 1997·Health Economics·M J BuxtonM Vray
Oct 7, 1997·BMJ : British Medical Journal·A Giuffrida, D J Torgerson
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·P L Chan, N H Holford
Mar 8, 2003·BMJ : British Medical Journal·Jim ChilcottUNKNOWN Cost Effectiveness of Multiple Sclerosis Therapies Study Group
Jul 24, 2004·BMJ : British Medical Journal·Michael D Rawlins, Anthony J Culyer
Feb 11, 2005·Applied Health Economics and Health Policy·Garry R BartonQuentin A Summerfield
Oct 27, 2005·Investigative Ophthalmology & Visual Science·Mireia EspallarguesJohn E Brazier
Feb 24, 2006·Health Economics·Mark J SculpherChris McCabe
Jul 20, 2007·The Cochrane Database of Systematic Reviews·H SturmJ P Kösters
Nov 1, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Dyfrig HughesUNKNOWN International Society for Pharmacoeconomics & Outcomes Research Economics of Medication Compliance Working Group
Jan 16, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Rachel A ElliottDyfrig A Hughes
Jul 24, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Yaling YangKarin Coyne
Oct 3, 2008·International Journal of Technology Assessment in Health Care·Susanne Hartz, Jürgen John
Jan 7, 2010·BMJ : British Medical Journal·Robin E FernerJeffrey K Aronson
Apr 29, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Simon WalkerMark Sculpher
Jul 9, 2010·Clinical Pharmacology and Therapeutics·N HolfordB A Ploeger
Aug 19, 2010·British Journal of Clinical Pharmacology·Dyfrig A Hughes
Aug 19, 2010·British Journal of Clinical Pharmacology·Michael RawlinsAndrew Stevens
Oct 7, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Yaling YangTracey A Young
May 1, 2009·Therapeutic Advances in Neurological Disorders·David ChadwickTony Marson
Jan 27, 2011·BMJ : British Medical Journal·Theresa M MarteauMichael P Kelly
May 26, 2011·BMJ : British Medical Journal·John Appleby
Jul 9, 2011·PharmacoEconomics·Dyfrig A Hughes

❮ Previous
Next ❯

Citations

Apr 20, 2014·BMC Health Services Research·James GallagherSuzanne McCarthy
Aug 1, 2020·PharmacoEconomics·Meenakshi SrinivasanLa'Marcus T Wingate

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.